Amy Quinlan
Chief Accounting Officer
Vor Biopharma Inc. (VOR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Amy Quinlan
Amy Quinlan is recorded as Chief Accounting Officer at Vor Biopharma Inc. (VOR). Vor Biopharma Inc. reported in an 8-K filed June 10, 2024 that Amy Quinlan was appointed interim principal accounting officer, effective June 21, 2024.
“On June 8, 2024, the Board designated Robert Ang, M.B.B.S., M.B.A., the Company's President and Chief Executive Officer and a director of the Company, as the Company's interim principal financial officer and Amy Quinlan, the Company's Vice President of Finance, as the Company's interim principal accounting officer, effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vor Biopharma Inc.
Other people whose current roles at this company are on record from its filings.
- Jean-Paul Kress CEO, Chairman, Board Member
- Jean-Paul Kress, M.D. CEO, Chairman, Board Member
- Han Choi, M.D., LL.M. CFO
- Robert Ang, M.B.B.S., M.B.A. CFO, Chief Accounting Officer
- Sandesh Mahatme CFO
- Sandy Mahatme CFO
- Alexander (Bo) Cumbo Board Member
- Andrew Levin Board Member
- David Zaccardelli, Pharm.D. Board Member
- Erez Kalir Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.